The Europe Anastomosis Devices Market is expected to witness market growth of 4.7% CAGR during the forecast period (2022-2028).
Anastomosis devices are often utilized in coronary artery bypass surgery to enhance the left ventricular system's operational efficiency and boost the patient's survival rate. Additionally, in developed economies, technical advancements and favorable healthcare spending scenarios in cardiac treatments like percutaneous coronary intervention, coronary artery bypass graft, and open-heart valve replacement are accelerating the growth of the anastomosis Market. Moreover, the rising demand for minimally invasive surgeries for coronary artery bypass graft surgery, the utilization of anastomosis devices in other surgeries such as orthopedic, gynecological, and ophthalmic surgeries, as well as various benefits of anastomosis devices such as stenosis are driving the Market. Further, when compared to traditional methods, lower vessel leakage and occlusion risks are likely to propel the anastomosis devices Market forward. Furthermore, the demand for better patient outcomes is expected to boost the adoption of novel anastomosis device advancements and contribute to Market growth.
According to the National Library of Medicines, the CVD is responsible for more than half of all fatalities in Europe. Lower socioeconomic levels had a greater CVD mortality rate. CVD deaths account for three-quarters of all deaths in poor nations. In addition, CVD is expected to kill more people in developing nations in 2030 than infectious, dietary, maternal, and perinatal illnesses combined. The screening as well as the treatment of people suffering from CVRF is limited in underdeveloped nations due to a lack of an effective primary care network.
Cardiovascular risk factor prevention has been proven to be effective. Interventions, such as policies against smoking and unfavorable eating habits, and promoting physical activity, on a big scale are feasible. Individual actions are available, both in primary prevention and secondary prevention. From a macroeconomic standpoint, these interventions are both effective and profitable.
The Germany Market dominated the Europe Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $310.3 million by 2028. The UK Market is poised to grow at a CAGR of 3.8% during (2022-2028). Additionally, The France Market is expected to witness a CAGR of 5.5% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Country
Anastomosis devices are often utilized in coronary artery bypass surgery to enhance the left ventricular system's operational efficiency and boost the patient's survival rate. Additionally, in developed economies, technical advancements and favorable healthcare spending scenarios in cardiac treatments like percutaneous coronary intervention, coronary artery bypass graft, and open-heart valve replacement are accelerating the growth of the anastomosis Market. Moreover, the rising demand for minimally invasive surgeries for coronary artery bypass graft surgery, the utilization of anastomosis devices in other surgeries such as orthopedic, gynecological, and ophthalmic surgeries, as well as various benefits of anastomosis devices such as stenosis are driving the Market. Further, when compared to traditional methods, lower vessel leakage and occlusion risks are likely to propel the anastomosis devices Market forward. Furthermore, the demand for better patient outcomes is expected to boost the adoption of novel anastomosis device advancements and contribute to Market growth.
According to the National Library of Medicines, the CVD is responsible for more than half of all fatalities in Europe. Lower socioeconomic levels had a greater CVD mortality rate. CVD deaths account for three-quarters of all deaths in poor nations. In addition, CVD is expected to kill more people in developing nations in 2030 than infectious, dietary, maternal, and perinatal illnesses combined. The screening as well as the treatment of people suffering from CVRF is limited in underdeveloped nations due to a lack of an effective primary care network.
Cardiovascular risk factor prevention has been proven to be effective. Interventions, such as policies against smoking and unfavorable eating habits, and promoting physical activity, on a big scale are feasible. Individual actions are available, both in primary prevention and secondary prevention. From a macroeconomic standpoint, these interventions are both effective and profitable.
The Germany Market dominated the Europe Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $310.3 million by 2028. The UK Market is poised to grow at a CAGR of 3.8% during (2022-2028). Additionally, The France Market is expected to witness a CAGR of 5.5% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Disposable and
- Reusable
- Cardiovascular Surgery
- Gastrointestinal Surgery and
- Others
- Hospitals and
- Ambulatory Care Centers & Clinics
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Anastomosis Devices Market by Product Type
Chapter 4. Europe Anastomosis Devices Market by Application
Chapter 5. Europe Anastomosis Devices Market by End User
Chapter 6. Europe Anastomosis Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Methodology
LOADING...
